CD1-MR1 2015* , ,
Presentations this author is a contributor to:
NKT cells can enhance Th1-based anti-tumour immunity to advanced cancers in vaccine models and in patients (#74)
9:05 AM
Mark A. Exley
Session 10 - Autoimmunity/Cancer I